BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22484807)

  • 1. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors.
    Berger AM; Hertzog M; Geary CR; Fischer P; Farr L
    J Cancer Surviv; 2012 Sep; 6(3):305-14. PubMed ID: 22484807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.
    Berger AM; Wielgus K; Hertzog M; Fischer P; Farr L
    Support Care Cancer; 2010 Jan; 18(1):105-14. PubMed ID: 19381692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
    Wielgus KK; Berger AM; Hertzog M
    Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
    Sultan A; Choudhary V; Parganiha A
    Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.
    Rogers VE; Zhu S; Mandrell BN; Ancoli-Israel S; Liu L; Hinds PS
    Support Care Cancer; 2020 Mar; 28(3):1459-1467. PubMed ID: 31273507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy.
    Liu L; Rissling M; Natarajan L; Fiorentino L; Mills PJ; Dimsdale JE; Sadler GR; Parker BA; Ancoli-Israel S
    Sleep; 2012 Feb; 35(2):237-45. PubMed ID: 22294814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.
    Ancoli-Israel S; Liu L; Marler MR; Parker BA; Jones V; Sadler GR; Dimsdale J; Cohen-Zion M; Fiorentino L
    Support Care Cancer; 2006 Mar; 14(3):201-9. PubMed ID: 16010529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment.
    Roscoe JA; Morrow GR; Hickok JT; Bushunow P; Matteson S; Rakita D; Andrews PL
    Support Care Cancer; 2002 May; 10(4):329-36. PubMed ID: 12029433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.
    Ratcliff CG; Lam CY; Arun B; Valero V; Cohen L
    Psychooncology; 2014 Nov; 23(11):1220-8. PubMed ID: 24706506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of circadian parameters and the clustering of fatigue, depression, and sleep problems in breast cancer survivors: a latent class analysis.
    de Rooij BH; Ramsey I; Clouth FJ; Corsini N; Heyworth JS; Lynch BM; Vallance JK; Boyle T
    J Cancer Surviv; 2023 Oct; 17(5):1405-1415. PubMed ID: 35318570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.
    Ancoli-Israel S; Liu L; Rissling M; Natarajan L; Neikrug AB; Palmer BW; Mills PJ; Parker BA; Sadler GR; Maglione J
    Support Care Cancer; 2014 Sep; 22(9):2535-45. PubMed ID: 24733634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
    Perez EA; Geeraerts L; Suman VJ; Adjei AA; Baron AT; Hatfield AK; Maihle N; Michalak JC; Kuross SA; Kugler JW; Lafky JM; Ingle JN
    Ann Oncol; 2002 Aug; 13(8):1225-35. PubMed ID: 12181246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian activity rhythms and fatigue of adolescent cancer survivors and healthy controls: a pilot study.
    Rogers VE; Mowbray C; Zhu S; Liu L; Ancoli-Israel S; Barr EA; Hinds PS
    J Clin Sleep Med; 2020 Jul; 16(7):1141-1147. PubMed ID: 32267222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study.
    Berger AM; Higginbotham P
    Oncol Nurs Forum; 2000 Oct; 27(9):1443-8. PubMed ID: 11058976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy.
    Berger AM; Farr LA; Kuhn BR; Fischer P; Agrawal S
    J Pain Symptom Manage; 2007 Apr; 33(4):398-409. PubMed ID: 17397701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
    Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
    Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.
    Lengacher CA; Johnson-Mallard V; Post-White J; Moscoso MS; Jacobsen PB; Klein TW; Widen RH; Fitzgerald SG; Shelton MM; Barta M; Goodman M; Cox CE; Kip KE
    Psychooncology; 2009 Dec; 18(12):1261-72. PubMed ID: 19235193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer.
    Yazilitas D; Sendur MA; Karaca H; Ozdemir N; Aksoy S; Berk V; Yazici O; Ozturk B; Ozkan M; Zengin N; Altundag K
    Asian Pac J Cancer Prev; 2015; 16(4):1471-7. PubMed ID: 25743817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer.
    Mortimer JE; Waliany S; Dieli-Conwright CM; Patel SK; Hurria A; Chao J; Tiep B; Behrendt CE
    Cancer; 2017 May; 123(10):1810-1816. PubMed ID: 28061004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Treatment Symptoms of Pain, Anxiety, Sleep Disturbance, and Fatigue in Breast Cancer Survivors.
    Schreier AM; Johnson LA; Vohra NA; Muzaffar M; Kyle B
    Pain Manag Nurs; 2019 Apr; 20(2):146-151. PubMed ID: 30527856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.